Impact of non-alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi-cohort longitudinal study.

Lijun ZhaoQingyue ZengXiaoqin ZhouLinqiao TangYujia WangQianqian HanYutong ZouXiang XiaoKe LiuXuegui JuYucheng WuXingyuan LiChuanyi ZhaoFang Liu

Published in: Diabetes, obesity & metabolism (2024)

In patients with type 2 diabetes and chronic kidney disease, the NAFLD presence and elevated FIB-4 scores link to heightened mortality risk and ESKD susceptibility. Moreover, NAFLD shows a causal relationship with cardio-cerebrovascular events.

Keyphrases

chronic kidney disease
end stage renal disease
liver fibrosis
cardiovascular events
peritoneal dialysis
risk factors
cardiovascular disease
coronary artery disease
adipose tissue
metabolic syndrome